Artificial intelligence and laboratory medicine: at the crossroads of value ethics and liability

Pages: 73-74
Damien Gruson, Pradeep Kumar Dabla

1Pôle de recherché an Endocrinology, Diabetes et Nutrition, Institute de Recherché Experimental et Clinique, Clinique’s Universities St-Luc and University Catholique de Louvain, Brussels, Belgium.

2Department of Clinical Biochemistry, Clinique’s Universities St-Luc and University Catholique de Louvain, Brussels, Belgium

3Department of Biochemistry, G.B. Pant Institute of Postgraduate Medical Education & Research, Associated Maulana Azad Medical College, New Delhi, India

Corresponding Author

Prof. Damien Gruson,damien.gruson@saintluc.uclouvain.be

Abstract

Laboratory medicine plays a pivotal role in healthcare and provides essential diagnostic information to guide clinical decision-making. Emerging technologies such as next-generation sequencing, liquid biopsies, and omics have transformed diagnostic testing on the way of a more personalized medicine. These technologies enable healthcare professionals to obtain more precise and accurate diagnostic information, which can lead to more targeted therapies. Artificial intelligence (AI) is also revolutionizing laboratory medicine with the potential to leverage value at different levels such as improving patient outcomes, clinical laboratories efficiencies and allocation of resources.